Immunome, Inc. (IMNM)
NASDAQ: IMNM · Real-Time Price · USD
11.59
+1.43 (14.07%)
At close: Sep 26, 2025, 4:00 PM EDT
11.70
+0.11 (0.94%)
After-hours: Sep 26, 2025, 7:59 PM EDT
Immunome Analyst Ratings
Total Analysts
9
Consensus Rating
Strong Buy
Price Target
$24.89
Upside
+114.75%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Strong Buy Initiates $26 | Strong Buy | Initiates | $26 | +124.33% | Sep 22, 2025 |
| Craig-Hallum | Craig-Hallum | Strong Buy Initiates $26 | Strong Buy | Initiates | $26 | +124.33% | Sep 5, 2025 |
| Guggenheim | Guggenheim | Strong Buy Reiterates $25 | Strong Buy | Reiterates | $25 | +115.70% | Aug 25, 2025 |
| Evercore ISI Group | Evercore ISI Group | Buy Initiates $18 | Buy | Initiates | $18 | +55.31% | Aug 22, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $23 → $22 | Buy | Maintains | $23 → $22 | +89.82% | Aug 7, 2025 |
| Lake Street | Lake Street | Strong Buy Initiates $23 | Strong Buy | Initiates | $23 | +98.45% | Apr 2, 2025 |
| Wedbush | Wedbush | Buy Reiterates $33 | Buy | Reiterates | $33 | +184.73% | Mar 20, 2025 |
| Stephens & Co. | Stephens & Co. | Buy Reiterates $30 | Buy | Reiterates | $30 | +158.84% | Mar 20, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $35 → $25 | Strong Buy | Maintains | $35 → $25 | +115.70% | Mar 20, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $23 → $21 | Buy | Maintains | $23 → $21 | +81.19% | Nov 14, 2024 |
| Stephens & Co. | Stephens & Co. | Buy Initiates $30 | Buy | Initiates | $30 | +158.84% | Nov 8, 2024 |
| Wedbush | Wedbush | Buy Reiterates $33 | Buy | Reiterates | $33 | +184.73% | Oct 25, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $27 → $23 | Buy | Maintains | $27 → $23 | +98.45% | Aug 13, 2024 |
| Wedbush | Wedbush | Buy Reiterates $33 | Buy | Reiterates | $33 | +184.73% | Aug 13, 2024 |
| Piper Sandler | Piper Sandler | Buy Initiates $27 | Buy | Initiates | $27 | +132.96% | May 31, 2024 |
| JP Morgan | JP Morgan | Buy Initiates $24 | Buy | Initiates | $24 | +107.08% | Apr 30, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.